Barclays
-
Vaccine bond marks issuer’s triumphant, if pricey, return to sterling
-
Vaccine financier marketing trade amid major disruption in UK politics
-
UK luxury carmaker opts for Saudi participation over Chinese control
-
New issue concessions on the rise in final major week of issuance before expected summer lull
-
Coupon difference between deals printed a year apart highlights direction of market
-
Hydrogen company opts for rights issue to fund projects in tricky market
-
UK issuer restarts additional tier one issuance from Europe after three year hiatus
-
German agency deal more than three times oversubscribed though new issue concessions inching up
-
Volatile debt markets continue to punish SSA issuers across the spectrum
-
The Israeli bank raised $800m to grow its credit portfolio
-
New deal is expected to refinance outstanding additional tier note at cheaper cost than extending it
-
After a sharp slump in corporate finance revenues, investment banks are facing an uncertain second half of the year. If previous downturns are a guide, job cuts will be inevitable before a new market reality emerges to trigger the next wave of capital markets and M&A activity. By David Rothnie